Novel Phenyl-Based Bis-quaternary Ammonium Compounds as Broad-Spectrum Biocides.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
06 10 2021
Historique:
revised: 30 06 2021
received: 23 04 2021
pubmed: 13 7 2021
medline: 19 2 2022
entrez: 12 7 2021
Statut: ppublish

Résumé

Herein we report the synthesis and microbiological evaluation of novel phenyl based bis-quaternary ammonium compounds (bis-QACs). Using a simple 2-step synthetic route from dibromo- and dihydroxybenzenes, we obtained a structurally diverse broad panel of bis-QACs with topologically distinct bridging connections between pyridinium heads. Selected analogs possessed potent broad-spectrum biocidal activity against both bacterial and fungal pathogens: methicillin-resistant Staphylococcus aureus (ATCC 43300); Escherichia coli (ATCC 25922), Klebsiella pneumonia (ATCC 700603), Acinetobacter baumannii (ATCC 19606), Pseudomonas aeruginosa (ATCC 27853), Candida albicans (ATCC 90028), Cryptococcus neoformans var. grubii (ATCC 208821). Promising compounds displayed minimum inhibitory concentrations (MIC) values ≤0.25 μg/mL alongside improved cytotoxicity and hemolytic profiles compared to modern antiseptics. Thus, synthesized bis-QACs represent a promising class of biocides with the potential to replace existing household sanitizers.

Identifiants

pubmed: 34252992
doi: 10.1002/cmdc.202100284
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antifungal Agents 0
Disinfectants 0
Quaternary Ammonium Compounds 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2954-2959

Subventions

Organisme : Russian Science Foundation
ID : 17-73-20260
Organisme : Wellcome Trust (UK)
Organisme : University of Queensland (Australia)

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

Directive 98/8/ec of the european parliament and of the council of 16 February 1998 concerning the placing of biocidal products on the market, (Ed.: T. E. P. A. T. C. O. T. E. Union), 1998.
 
W. A. Jacobs, J. Exp. Med. 1916, 23(5), 563-568;
W. A. Jacobs, M. Heidelberger, H. L. Amoss, J. Exp. Med. 1916, 23(5), 569-576;
W. A. Jacobs, M. Heidelberger, C. G. Bull J. Exp. Med. 1916, 23(5), 577-599.
G. Domagk, Dtsch. Med. Wochenschr. 1935, 61, 829-832.
G. Zheng, G. M. Filippelli, A. Salamova, Environ. Sci. Technol. Lett. 2020, 7(10), 760-765.
C. L. Schrank, K. P. C. Minbiole, W. M. Wuest, ACS Infect. Dis. 2020, 6(7), 1553-1557.
M. C. Jennings, K. P. C. Minbiole, W. M. Wuest, ACS Infect. Dis. 2015, 1(7), 288-3030.
 
F. M. Menger, C. A. Littau, J. Am. Chem. Soc. 1993, 115(22), 10083-10090;
M. S. Kamal, J. Surf. Det. 2016, 19(2), 223-236.
D. M. Bailey, C. G. DeGrazia, S. J. Hoff, P. L. Schulenberg, J. R. O′Connor, D. A. Paris, A. M. Slee, J. Med. Chem. 1984, 27(11), 1457-1464.
E. Obłąk, A. Piecuch, J. Rewak-Soroczyńska, E. Paluch, Appl. Microbiol. Biotechnol. 2019, 103(2), 625-632.
 
M. C. Grenier, R. W. Davis, K. L. Wilson-Henjum, J. E. LaDow, J. W. Black, K. L. Caran, K. Seifert, K. P. C. Minbiole, Bioorg. Med. Chem. Lett. 2012, 22(12), 4055-408;
S. E. Al-Khalifa, M. C. Jennings, W. M. Wuest, K. P. C. Minbiole, ChemMedChem. 2016, 12(4), 280-283;
K. R. Morrison, R. A. Allen, K. P. C. Minbiole, W. M. Wuest, Tetrahedron Lett. 2019, 60(37), 150935;
S. Alkhalifa, M. C. Jennings, D. Granata, M. Klein, W. M. Wuest, K. P. C. Minbiole, V. Carnevale, ChemBioChem. 2020, 21(10), 1510-1516;
A. J. Leitgeb, J. A. Feliciano, H. A. Sanchez, R. A. Allen, K. R. Morrison, K. J. Sommers, R. G. Carden, W. M. Wuest, K. P. C. Minbiole, ChemMedChem. 2020, 15(8), 667-670;
M. A. Garrison, A. R. Mahoney, W. M. Wuest, ChemMedChem. 2020, 16(3), 463-466.
 
A. N. Vereshchagin, N. A. Frolov, V. Y. Konyuhova, K. A. Hansford, M. P. Egorov, Mendeleev Commun. 2019, 29(5), 523-525;
A. N. Vereshchagin, A. M. Gordeeva, N. A. Frolov, P. I. Proshin, K. A. Hansford, M. P. Egorov, Eur. J. Org. Chem. 2019, 2019(26), 4123-4127;
A. N. Vereshchagin, N. A. Frolov, V. Y. Konyuhova, E. O. Dorofeeva, K. A. Hansford, M. P. Egorov, Mendeleev Commun. 2020, 30(4), 424-426;
A. N. Vereshchagin, N. A. Frolov, A. S. Pakina, K. A. Hansford, M. P. Egorov, Mendeleev Commun. 2020, 30(6), 703-705;
A. N. Vereshchagin, N. A. Frolov, V. Y. Konyuhova, E. A. Kapelistaya, K. A. Hansford, M. P. Egorov, RSC Adv. 2021, 11(6), 3429-3438;
A. N. Vereshchagin, N. A. Frolov, K. S. Egorova, M. M. Seitkalieva, V. P. Ananikov, Int. J. Mol. Sci. 2021, 22(13), 6793.
 
K. Roy, S. Kar, R. N. Das, A Primer on QSAR/QSPR Modeling Springer International Publishing, 2015;
A. N. Vereshchagin, Russ. Chem. Bull. 2017, 66(10), 1765-1796;
C. Zhou, Y. Wang, Curr. Opin. Colloid Interface Sci. 2020, 45, 28-43;
A. N. Vereshchagin, M. N. Elinson, Y. E. Anisina, F. V. Ryzhkov, A. S. Goloveshkin, R. A. Novikov, M. P. Egorov, J. Mol. Struct. 2017, 1146, 766-772.
Y. Tsuji, M. Yamamoto, A. N. Vereshchagin, A. S. Dorofeev, T. A. Geyvandova, I. F. Agafonova, R. K. Geyvandov, WO158045, 2014.
 
M. Yamamoto, T. Takami, R. Matsumura, A. Dorofeev, Y. Hirata, H. Nagamune, Biocontrol Sci. 2016, 21(4), 231-241;
M. Yamamoto, R. Matsumura, Y. Hirata, H. Nagamune, Toxicol. in Vitro 2019, 54, 75-81.
 
Y. Liu, W. Zhang, J. Zhang, Patent, 2016, CN 104262159;
M. Rovira, L. Jašíková, E. Andris, F. Acuña-Parés, M. Soler, I. Güell, M.-Z. Wang, L. Gómez, J. M. Luis, J. Roithová, X. Ribas, Chem. Commun. 2017, 53(62), 8786-8789.
M. A. T. Blaskovich, J. Zuegg, A. G. Elliott, M. A. Cooper, ACS Infect. Dis. 2015, 1(7), 285-287.
F. Devínsky, A. Kopecka-Leitmanová, F. Šeršeň, P. Balgavý, J. Pharm. Pharmacol. 1990, 42(11), 790-794.

Auteurs

Nikita A Frolov (NA)

N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991, Moscow, Russian Federation.

Ksenia A Fedoseeva (KA)

Mendeleev University of Chemical Technology of Russia, 125047, Miusskaya square 9, Moscow, Russian Federation.

Karl A Hansford (KA)

Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Anatoly N Vereshchagin (AN)

N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991, Moscow, Russian Federation.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH